BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37249427)

  • 21. Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplant According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
    Bae JS; Lee DH; Lee SM; Suh KS; Lee KW; Yi NJ; Lee KB; Kim H; Han JK
    AJR Am J Roentgenol; 2022 Jul; 219(1):86-96. PubMed ID: 35138137
    [No Abstract]   [Full Text] [Related]  

  • 22. Follow Up Imaging in Hepatocellular Cancer Ultrasound Screening Exams With Poor Visualization Scores.
    Bley E; Mohan N; Jackson I; Chaisidhivej N; Jarrett S; Lo KB; Navarro V; Rossi S; Rodgers SK; Kalman RS
    J Ultrasound Med; 2022 Dec; 41(12):3113-3118. PubMed ID: 36063062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI.
    Kwag M; Choi SH; Choi SJ; Byun JH; Won HJ; Shin YM
    Radiology; 2022 Dec; 305(3):614-622. PubMed ID: 35972362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound LI-RADS Visualization Scores on Surveillance Ultrasound for Hepatocellular Carcinoma: A Systematic Review With Meta-analysis.
    Kang JH; Kim NH; Kim DH; Choi Y; Choi JI
    Ultrasound Med Biol; 2023 Oct; 49(10):2205-2212. PubMed ID: 37517886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.
    Fraum TJ; Cannella R; Ludwig DR; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Shetty AS; Borhani AA; Furlan A; Fowler KJ
    Eur Radiol; 2020 Feb; 30(2):996-1007. PubMed ID: 31654212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
    Kim SY; An J; Lim YS; Han S; Lee JY; Byun JH; Won HJ; Lee SJ; Lee HC; Lee YS
    JAMA Oncol; 2017 Apr; 3(4):456-463. PubMed ID: 27657493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of LI-RADS US-2 Subthreshold Observations Detected on Surveillance Ultrasound.
    Tse JR; Shen L; Bird KN; Yoon L; Kamaya A
    AJR Am J Roentgenol; 2022 Nov; 219(5):774-783. PubMed ID: 35703411
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
    Cannella R; Matteini F; Dioguardi Burgio M; Sartoris R; Beaufrère A; Calderaro J; Mulé S; Reizine E; Luciani A; Laurent A; Seror O; Ganne-Carrié N; Wagner M; Scatton O; Vilgrain V; Cauchy F; Hobeika C; Ronot M
    Radiology; 2024 Feb; 310(2):e231160. PubMed ID: 38411519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma.
    Khanna G; Chavhan GB; Schooler GR; Fraum TJ; Alazraki AL; Squires JH; Salter A; Podberesky DJ; Towbin AJ
    Radiology; 2021 Apr; 299(1):190-199. PubMed ID: 33620289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic role of spleen volume measurement using computed tomography in patients with compensated chronic liver disease from hepatitis B viral infection.
    Yoo J; Kim SW; Lee DH; Bae JS; Cho EJ
    Eur Radiol; 2021 Mar; 31(3):1432-1442. PubMed ID: 32880698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 32. Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance.
    Chon YE; Jung KS; Kim MJ; Choi JY; An C; Park JY; Ahn SH; Kim BK; Kim SU; Park H; Hwang SK; Rim KS; Han KH; Kim DY
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1201-1212. PubMed ID: 29492988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of US LI-RADS in the LI-RADS Algorithm.
    Rodgers SK; Fetzer DT; Gabriel H; Seow JH; Choi HH; Maturen KE; Wasnik AP; Morgan TA; Dahiya N; O'Boyle MK; Kono Y; Sirlin CB; Kamaya A
    Radiographics; 2019; 39(3):690-708. PubMed ID: 31059393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B.
    Zhang T; Zhang G; Deng X; Zeng J; Jin J; Zeping H; Wu M; Zheng R
    Radiology; 2021 Nov; 301(2):350-359. PubMed ID: 34427463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI.
    Choi SH; Lee SS; Park SH; Kim KM; Yu E; Park Y; Shin YM; Lee MG
    Radiology; 2019 Feb; 290(2):388-397. PubMed ID: 30422088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
    Jiang XY; Huang B; Huang DP; Wei CS; Zhong WC; Peng DT; Huang FR; Tong GD
    World J Gastroenterol; 2021 Mar; 27(11):1101-1116. PubMed ID: 33776376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LI-RADS CT and MRI Ancillary Feature Association with Hepatocellular Carcinoma and Malignancy: An Individual Participant Data Meta-Analysis.
    Dawit H; Lam E; McInnes MDF; van der Pol CB; Bashir MR; Salameh JP; Levis B; Sirlin CB; Chernyak V; Choi SH; Kim SY; Fraum TJ; Tang A; Jiang H; Song B; Wang J; Wilson SR; Kwon H; Kierans AS; Joo I; Ronot M; Song JS; Podgórska J; Rosiak G; Kang Z; Allen BC; Costa AF
    Radiology; 2024 Feb; 310(2):e231501. PubMed ID: 38376399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
    Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J
    Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.